How to Buy Pharming Group Nv Stock

Pharming Group Nv

Pharming Group N. V. , a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally.

Pharming Group Nv stock last closed at $10.75, down 7.05% from the previous day, and has increased 25.04% in one year. It has overperformed other stocks in the Biotechnology industry by 1.01 percentage points. Pharming Group Nv stock is currently +61.65% from its 52-week low of $6.65, and -14.75% from its 52-week high of $12.61.

At the moment, there are 680.31M shares of PHAR outstanding. The market capitalization of PHAR is $731.33M. In the past 24 hours, 3800 PHAR shares were traded.

How to Buy Pharming Group Nv Stock

Wondering how to invest in Pharming Group Nv stock? Here's how.

  1. Decide where to buy Pharming Group Nv stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Pharming Group Nv stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your investment account: Select your payment method and add your info.
  4. Analyze Pharming Group Nv stock: The Pharming Group Nv ticker symbol is PHAR. Is Pharming Group Nv stock a good investment? Should you buy shares of PHAR? How do PHAR's underlying business fundamentals look? Do top analysts think Pharming Group Nv is a good buy? Why has PHAR's stock price moved recently? (Hint: Our stock research tools can help you decide if PHAR is a good stock to buy).
  5. Place your PHAR buy order: Decide if you will purchase PHAR shares at the current market price or use a limit order to purchase PHAR shares at a specific price.
  6. Watch your PHAR position: Create a watchlist to key updates about your position in Pharming Group Nv stock.

Step 1: Decide where to buy Pharming Group Nv stock

You need an online brokerage account in order to access the NASDAQ market and buy PHAR stock.

A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global financial markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PHAR stock today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to start a new trading account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have finished signing up on the best stock trading app for beginners, you need to deposit funds:

Check out the video below if you need help transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Pharming Group Nv stock

Once you have selected the best place to buy Pharming Group Nv stock, it's crucial to research their stock before you buy, so you truly wrap your head around the risk and upside.

Overview of key PHAR info

PHAR Price
$10.75
1w %
-9.34%
1y %
25.04%
5y %
N/A
P/E
-44.98x
P/B
3.01x
P/S
2.01x
PEG
N/A
Revenue
$364.44M
Earnings
-$16.04M
Fore. Rev. Growth
4.78%
Fore. Earn. Growth
N/A
Market Cap
$731.33M
Next Earnings
N/A
Next Dividend
N/A

Pharming Group Nv Due Diligence Checks

WallStreetZen was built to help average investors do more accurate fundamental analysis.

You can see all of the due diligence checks on PHAR's stock page.

Is PHAR stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge PHAR's intrinsic value.

Using relative valuations metrics:

  • PHAR could be undervalued based on its P/B ratio of 3.01x, relative to Biotechnology industry P/B ratio of 4.66x

You can do more valuation analysis on PHAR's stock here.

How do PHAR Financials look?

Passed Financial Due Diligence Checks:

  • There are more short-term assets than long-term liabilities on the PHAR balance sheet.
  • There are more short-term assets than short-term liabilities on the PHAR balance sheet.

Failed Financial Due Diligence Checks:

  • PHAR's operating cash flow of $6.91M allows it to safely service it's debt of $135.39M.
  • PHAR earnings of -$3.96M is not enough to cover its interest payments.
  • PHAR has a relatively high debt to equity ratio of 0.88.
  • PHAR profit margin has gone down from -4.2% to -4.4% in the past year.

Do Wall Street analysts think it's a good time to buy PHAR stock

Out of 2 Wall Street analysts who give forecasts on PHAR, the consensus analyst rating on Pharming Group Nv is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Pharming Group Nv stock forecast page.

PHAR Momentum

SMA10
11.5
SMA20
10.85
SMA50
9.52
SMA100
9.13
SMA200
8.8
MACD
0.56
MACD Signal
0.61
MACD Histogram
-0.06
RSI
51.45
Stochastic %K
49.16
Stochastic %D
57.41
StochRSI %K
17
StochRSI %D
25.37

PHAR Earnings

Last year, PHAR revenue was $364.44M. Over the past 4 year, PHAR's revenue has gone up by 10.15% per year. This was slower than the Biotechnology industry average of 43.24%.

Dive into PHAR's earnings and revenue performance here.

Latest Insiders Trades at PHAR

In the past 12 months, executives and large shareholders at PHAR have not bought or sold any shares.

Learn more about who owns PHAR shares here.

Does PHAR provide a stable income stream?

No, Pharming Group Nv doesn't provide an income stream by paying out dividends.

PHAR Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your PHAR buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific dollar amount limit, use a limit order.

Click the Open Trade button and your broker will execute your order.

If you need more help with buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Watch your PHAR position

Now that you own some PHAR stock, you'll want to stay up-to-date on your new investment.

Make a watchlist to see the latest developments about your PHAR stock.

PHAR Feed

How to Buy Stock in Pharming Group Nv

To summarize, here are the 6 steps to buy Pharming Group Nv stock:

  1. Decide where to buy Pharming Group Nv stock
  2. Create your brokerage account
  3. Fund your investment account
  4. Analyze Pharming Group Nv stock
  5. Place your PHAR buy order
  6. Watch your PHAR position

If you need a brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get updates on your investment in Pharming Group Nv, create a watchlist today.

NASDAQ: PHAR
$10.75-0.82 (-7.05%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: PHAR
$10.75-0.82 (-7.05%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Pharming Group Nv share?

As of Jun 13, 2025, it costs $10.75 to buy one share of Pharming Group Nv stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.465 shares of PHAR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Pharming Group Nv stock?

According to 2 Wall Street analysts who monitor Pharming Group Nv, their consensus recommendation is to buy Pharming Group Nv stock.

What is the best way to buy Pharming Group Nv stock?

One way to place an order for Pharming Group Nv stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.